Skip to content

Influence of central venous pressure reducing manouvres on the postoperative outcome in patients undergoing major liver surgery

The influence of two different central venous pressure (CVP) reducing regimes used in patients undergoing liver resection using low CVP anesthesia principle on their clinical outcome, hemodynamic stability and global oxygen balance.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617000484347
Acronym
HOLIRES (Hemodynamic Optimization in LIver REsection Surgery)
Enrollment
34
Registered
2017-04-03
Start date
2012-01-11
Completion date
2015-02-04
Last updated
2017-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the study is to compare the effectivity of two methods of lowering central venous pressure (CVP) on the ease to reach the predefined target of CVP lower than 5 mmHg. Patients´ postoperative outcome assessed via composite morbidity (complications rate) and mortality till 30 days and hospital length of stay as well as intraoperative safety outcomes (hemodynamic stability, markers of global oxygen debt, blood loss,) will be assessed, allowing to define simple, standardized and safe approach of low-CVP anesthesia.

Interventions

Comparison of two strategies of reaching low central venous pressure (Low-CVP; below 5 mmHg) during liver resection surgery. One strategy is using absolute fluid restriction (Arm 1 - intervention), the other one relative volume redistribution caused by systemic vasodilation (Arm 2 - control). Treatments in both groups will be administered by treating anaesthesiologist (member of the study team) according to the randomization during the preoperative (from morning till surgery) and intraoperative

Comparison of two strategies of reaching low central venous pressure (Low-CVP; below 5 mmHg) during liver resection surgery. One strategy is using absolute fluid restriction (Arm 1 - intervention), the other one relative volume redistribution caused by systemic vasodilation (Arm 2 - control). Treatments in both groups will be administered by treating anaesthesiologist (member of the study team) according to the randomization during the preoperative (from morning till surgery) and intraoperative period. Treatments in both arms will be graded into predefined steps. In the Arm 1 absolute restriction of circulating volume will be provided by reduction of preoperative fluids (neither intravenous nor oral intake 6 hours prior surgery) coupled with minimal (1ml/kg/hour, Ringerfundin solution - B´Braun) intraoperative intravenous supplementation. If needed, given the CVP value assessed by the treating anaesthesiologist, diuretics will be further administered (Furosemide 10mg intravenous per step, maximum 3 doses allowed i.e. up to three steps) to reach the low-CVP target. Participants will receive only the minimal number of steps required to reach the 5mmHg CVP target.

Sponsors

Dpt. of Anesthesia and Intensive Care of The Faculty of Medicine Plzen - Charles University Prague)
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

patients scheduled for hepatic resection of more than 2 liver segments, general anesthesia, regullar heart rhythm, signed informed consent

Exclusion criteria

body weight less than 50 kg or more than 150 kg, irregular heart rythm, severe cardiovascular disease (chronic heart failure, valvular abnormality, cardiomyopathy etc.), severe liver dysfunction (Child Pugh score B or C)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026